Interactive program
Tuesday 19 March 2024
-
Standard presentation Copper Hall
Afternoon (CET)
SEPSIS: BACK TO BASICS
Moderator(s):
Lennie Derde (Utrecht, Netherlands)
Frank van Haren (Sydney, Australia)
Frank van Haren (Sydney, Australia)
-
-
What do we mean by ´dysregulated immune response`?
Manu Shankar–Hari (Edinburgh, United Kingdom)
Wednesday 20 March 2024
-
Standard presentation Panoramic Room
Morning (CET)
REASSESSING ARDS
Moderator(s):
John J Marini (St Paul, United States)
Antoine Vieillard–Baron (Boulogne-Billancourt, France)
Antoine Vieillard–Baron (Boulogne-Billancourt, France)
-
-
Do patients die of or with ARDS?
Manu Shankar–Hari (Edinburgh, United Kingdom)
-
Round table The Arc Room
Afternoon (CET)
-
-
Treatable traits versus sub phenotypes
Evangelos Giamarellos–Bourboulis (Athens, Greece)
Patricia Rocco (Rio De Janeiro, Brazil)
Christopher Seymour (Pittsburgh, United States)
Manu Shankar–Hari (Edinburgh, United Kingdom)
Thursday 21 March 2024
-
Standard presentation 100 Hall
Afternoon (CET)
PERSONALIZING SEPSIS
Moderator(s):
Liesbet De Bus (Ghent, Belgium)
Mervyn Singer (London, United Kingdom)
Mervyn Singer (London, United Kingdom)
-
-
Immune states are better than sub phenotypes
Manu Shankar–Hari (Edinburgh, United Kingdom)
Friday 22 March 2024
-
Pro-con debate 400 Hall
Morning (CET)
-
-
Corticosteroids in ARDS
PRO: Djillali Annane (Garches, France)
CON: Manu Shankar–Hari (Edinburgh, United Kingdom)